||A major contributor to this article appears to have a close connection with its subject. (May 2017) (Learn how and when to remove this template message)|
|This article needs additional citations for verification. (May 2017) (Learn how and when to remove this template message)|
|Public (NASDAQ: NUVA)|
|Headquarters||San Diego, California|
|Gregory T. Lucier, Chairman of the Board and CEO|
|Revenue||$962 million (2016)|
NuVasive, Inc., based in San Diego, California, is a global medical device company focused on transforming spine surgery by empowering surgeons with technology to approach procedures in the least disruptive way possible and restore the vitality of life for those that suffer from debilitating spinal conditions. Their mission statement is to improve the lives of patients who suffer from debilitating back, neck, or leg pain by creating cutting-edge products and procedures that revolutionize spine surgery through focusing on Speed of Innovation®, Absolute Responsiveness®, and Superior Clinical Results.
Through innovative technological advancements, NuVasive has successfully progressed major spine surgery to where many patients have experienced extraordinary results—they are often walking the same day of surgery, experiencing less blood loss, spending less time in the hospital, and going back to work within four to six weeks (versus six months).
NuVasive is the 3rd largest company in the $9 billion global spine market and is publicly traded on the NASDAQ under the symbol NUVA.
NuVasive offers more than 90 products spanning lumbar, thoracic, and cervical applications, neuromonitoring services, and a biologics portfolio. Their most popular devices are used in spinal surgery.
- XLIF - a minimally disruptive surgical procedure performed through the side of the body
- ACDF - cervical spine surgery from the front of the neck that addresses spinal symptoms
- ALIF - a procedure where surgeons work on the lower spine from the front and fuse one or more vertebrae together
- CoRoent Small Interbody System - interbody cage cleared for use in up to 4 contiguous cervical-disk levels
On June 6, 2016, NuVasive acquired Biotronic Neuronetwork, the nation's leader in intraoperative neurophysiological monitoring. Biotronic strives to provide the highest quality intraoperative neural monitoring services supported by an industry leading quality assurance program.
On March 7, 2016, NuVasive acquired Mega Surgical, the exclusive distributor of NuVasive products in Brazil. Mega Surgical was founded in 1996 as an implantable medical device distribution company.
On January 5, 2016, NuVasive acquired Ellipse Technologies, a privately held medical technology company focused on revolutionizing procedural solutions for complex skeletal deformity and leg lengthening with patented technologies involving External Remote Controllers (ERC).
In 2015, NuVasive was forced to pay the United States $13.5 million to resolve allegations that they made health care providers submit false Medicare claims for spine surgeries by marketing the company’s CoRoent System for surgical uses that were not approved by the U.S. Food and Drug Administration.
- The NuVasive Spine Foundation is dedicated to providing life-changing spine surgery to individuals in disadvantaged communities across the globe and advancing spine surgery technology in these communities by training local surgeons.
- The Better Way Back is a program built on the power of empathy dedicated to building a community that provides hope, support, and information to patients suffering from chronic back, leg, or neck pain.
- "https://docnovo.com/fda-devices/510k/NuVasiveSpecializedOrthopedics,Inc./NuVasiveCoRoentSmallInterbodySystem/K163491". docnovo.com. Retrieved 2017-05-19. External link in
- "Medical Device Manufacturer NuVasive Inc. to Pay $13.5 Million to Settle False Claims Act Allegations". www.justice.gov. Retrieved 2017-05-19.